Other Non-Current Liabilities
Thermo Fisher Scientific Other Non-Current Liabilities increased by 3.5% to $4.42B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.3%, from $3.97B to $4.42B. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 5.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
Detailed definition
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peer comparison
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.51B | $3.98B | $4.54B | $4.66B | $4.53B | $4.40B | $4.24B | $4.23B | $4.04B | $4.33B | $4.64B | $4.57B | $4.39B | $4.34B | $3.99B | $3.97B | $4.27B | $4.28B | $4.27B | $4.42B |
| QoQ Change | — | +13.4% | +14.0% | +2.7% | -2.8% | -2.9% | -3.7% | -0.2% | -4.4% | +7.0% | +7.3% | -1.6% | -3.9% | -1.1% | -8.2% | -0.5% | +7.5% | +0.2% | -0.1% | +3.5% |
| YoY Change | — | — | — | — | +29.0% | +10.5% | -6.7% | -9.3% | -10.9% | -1.7% | +9.5% | +8.0% | +8.6% | +0.4% | -14.1% | -13.1% | -2.8% | -1.5% | +7.1% | +11.3% |
Other Non-Current Liabilities at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's other non-current liabilities?
- Thermo Fisher Scientific (TMO) reported other non-current liabilities of $4.42B in Q1 2026.
- How has Thermo Fisher Scientific's other non-current liabilities changed year-over-year?
- Thermo Fisher Scientific's other non-current liabilities increased by 11.3% year-over-year, from $3.97B to $4.42B.
- What is the long-term trend for Thermo Fisher Scientific's other non-current liabilities?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's other non-current liabilities has grown at a 5.1% compound annual growth rate (CAGR), from $3.33B to $4.27B.
- What does other non-current liabilities mean?
- Miscellaneous long-term financial obligations not classified under standard debt or liability categories.